Operating income decreased 76.3%
Operating income changed -76.3% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed -76.3% from the comparable as-filed period.
Research & development changed -76.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory changed +31.5% from the comparable as-filed period.
Current assets changed +133.3% from the comparable as-filed period.
Stock-based compensation changed +67.5% from the comparable as-filed period.
Working capital changed +53.6% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.